Saad, A http://orcid.org/0000-0003-0003-0130
Lamb, L S
Article History
Received: 17 October 2016
Revised: 5 December 2016
Accepted: 15 December 2016
First Online: 20 March 2017
Competing interests
: AS discloses grant support (American Porphyria foundation), consultation (Medpace Inc), research support (Astellas and Fate Therapeutics), honoraria (Alxion, and Spectrum), and royalty for licensing of intellectual property (Incysus Biomedical). LSL is a scientific founder of Incysus, Ltd and a member of their Scientific Advisory Board.